Article Versions Notes

Ding C, Tang W, Xia B, Peng H, Liu Y, Wang J, Zheng X, Liu Y, Zhao L, He Y, et al. High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses. Viruses. 2022; 14(7):1381. https://doi.org/10.3390/v14071381

Ding, Cuiling, Wanda Tang, Binghui Xia, Haoran Peng, Yan Liu, Jiaqi Wang, Xu Zheng, Yangang Liu, Lanjuan Zhao, Yanhua He, and et al. 2022. "High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses" Viruses 14, no. 7: 1381. https://doi.org/10.3390/v14071381

Ding, C., Tang, W., Xia, B., Peng, H., Liu, Y., Wang, J., Zheng, X., Liu, Y., Zhao, L., He, Y., Qi, Z., Ren, H., Tang, H., & Zhao, P. (2022). High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses. Viruses, 14(7), 1381. https://doi.org/10.3390/v14071381